Unknown

Dataset Information

0

STING inhibitors target the cyclic dinucleotide binding pocket.


ABSTRACT: Cytosolic DNA activates cGAS (cytosolic DNA sensor cyclic AMP-GMP synthase)-STING (stimulator of interferon genes) signaling, which triggers interferon and inflammatory responses that help defend against microbial infection and cancer. However, aberrant cytosolic self-DNA in Aicardi-Goutière's syndrome and constituently active gain-of-function mutations in STING in STING-associated vasculopathy with onset in infancy (SAVI) patients lead to excessive type I interferons and proinflammatory cytokines, which cause difficult-to-treat and sometimes fatal autoimmune disease. Here, in silico docking identified a potent STING antagonist SN-011 that binds with higher affinity to the cyclic dinucleotide (CDN)-binding pocket of STING than endogenous 2'3'-cGAMP. SN-011 locks STING in an open inactive conformation, which inhibits interferon and inflammatory cytokine induction activated by 2'3'-cGAMP, herpes simplex virus type 1 infection, Trex1 deficiency, overexpression of cGAS-STING, or SAVI STING mutants. In Trex1 -/- mice, SN-011 was well tolerated, strongly inhibited hallmarks of inflammation and autoimmunity disease, and prevented death. Thus, a specific STING inhibitor that binds to the STING CDN-binding pocket is a promising lead compound for STING-driven disease.

SUBMITTER: Hong Z 

PROVIDER: S-EPMC8214703 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7572726 | biostudies-literature
| S-EPMC7069516 | biostudies-literature
| S-EPMC7856189 | biostudies-literature
| S-EPMC8958419 | biostudies-literature
| S-EPMC10778758 | biostudies-literature
| S-EPMC4143541 | biostudies-literature
| S-EPMC8595610 | biostudies-literature
| S-EPMC6402974 | biostudies-literature
| S-EPMC7363834 | biostudies-literature
| S-EPMC8341399 | biostudies-literature